Atherosclerosis
Volume 195, Issue 2 , Pages 262-268, December 2007

Functional analysis of the genetic variability in the F7 gene promoter

  • Maria Sabater-Lleal

      Affiliations

    • Unitat d’Hemostàsia i Trombosi, Hospital de la Santa Creu i Sant Pau, Barcelona 08025, Spain
  • ,
  • Miguel Chillón

      Affiliations

    • Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona 08010, Spain
    • Centre de Biologia Animal i Teràpia Gènica (CBATEG), Department of Biochemistry and Molecular Biology, Universitat Autònoma de Barcelona, Barcelona 08193, Spain
  • ,
  • Tom E. Howard

      Affiliations

    • Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA
  • ,
  • Estel Gil

      Affiliations

    • Centre de Biologia Animal i Teràpia Gènica (CBATEG), Department of Biochemistry and Molecular Biology, Universitat Autònoma de Barcelona, Barcelona 08193, Spain
  • ,
  • Laura Almasy

      Affiliations

    • Southwest Foundation for Biomedical Research (SFBR), San Antonio, TX 78245, USA
  • ,
  • John Blangero

      Affiliations

    • Southwest Foundation for Biomedical Research (SFBR), San Antonio, TX 78245, USA
  • ,
  • Jordi Fontcuberta

      Affiliations

    • Unitat d’Hemostàsia i Trombosi, Hospital de la Santa Creu i Sant Pau, Barcelona 08025, Spain
  • ,
  • José Manuel Soria

      Affiliations

    • Unitat d’Hemostàsia i Trombosi, Hospital de la Santa Creu i Sant Pau, Barcelona 08025, Spain
    • Corresponding Author InformationCorresponding author at: Unitat d’Hemostàsia i Trombosi, Hospital de la Santa Creu i Sant Pau, C/Sant Antoni M. Claret 167, 08025 Barcelona, Spain. Tel.: +34 93 2919193; fax: +34 93 2919192.

Received 26 July 2006; received in revised form 24 November 2006; accepted 19 December 2006. published online 10 February 2007.

Abstract 

The FVII level is considered a risk factor for cardiovascular disease. Some of the polymorphic differences in the promoter of the F7 gene have been associated with variations in FVII levels. However, linkage disequilibrium among those polymorphisms has made it difficult to pinpoint the true functional variants, so contradictory results have often appeared among various studies.

We provide new findings of the effect of the polymorphisms in the promoter region of F7. In vitro transfection of 15 plasmids containing different combinations of F7 promoter polymorphisms was performed in HepG2 cells.

We found that allelic variants −323ins10 and −122C strongly reduced promoter activity and that allelic variant −402A significantly increased promoter activity. We report the effect of a novel variant (−2989A) that significantly increases F7 expression levels. However, this novel allelic variant is in strong linkage disequilibrium with the −323ins10 variant in our Spanish population, which has a clear dominant effect over the −2989A variant and completely masks its effect.

Our results have important implications for mapping genes affecting complex diseases using association studies. That is, they imply that true functional variants should be chosen to confirm the analyses and to ensure that the results can be reproduced in other populations. In addition, our results suggest that it would be informative to screen for the −2989A variant in other populations, since it may well be a risk factor for cardiovascular disease in populations where it does not appear with the decanucleotide insertion.

Abbreviations: FVII, Factor VII protein, F7, Factor VII gene, QTN, quantitative trait nucleotide, SNP, single nucleotide polymorphism, PCR, polymerase chain reaction, HNF, hepatic nuclear factor, GFP, green fluorescent protein, DMEM, Dulbecco's modified essential medium, PEI, polyethylenimine, WT, wild type

Keywords: F7, FVII, Functional analyses, Promoter expression

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0021-9150(07)00028-7

doi:10.1016/j.atherosclerosis.2006.12.031

Atherosclerosis
Volume 195, Issue 2 , Pages 262-268, December 2007